Menu Search
Equities

Elixirr International PLC

54K:FRA

Elixirr International PLC

Actions
  • Price (EUR)9.30
  • Today's Change0.05 / 0.54%
  • Shares traded495.00
  • 1 Year change+77.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 07:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Elixirr International plc is a global consulting firm working with clients across a diverse range of industries, markets and geographies. The Company is principally engaged in the provision of consulting services, delivering bespoke solutions to a globally recognized client base, including digital, data, artificial intelligence (AI) and transformation services. The Company’s subsidiaries include Hypothesis Group, LLC (Hypothesis), Den Creative Limited (Den Creative), The Retearn Group Limited (The Retearn Group), iOLAP Inc. (iOLAP), Responsum Inc (Responsum), Insigniam LLC (Insigniam), Elixirr Consulting Limited, Elixirr Digital Limited, Elixirr LLC, and others, as well as subsidiaries or branches in South Africa, France, Jersey and Croatia. Hypothesis help companies better understand their customers by providing insights, competitor intelligence and strategic advice to inform the design of products and services.

  • Revenue in GBP (TTM)97.78m
  • Net income in GBP18.41m
  • Incorporated2018
  • Employees452.00
  • Location
    Elixirr International PLC100 CheapsideLondon EC2V 6DTUnited KingdomGBR
  • Phone+44 207 220 5410
  • Websitehttps://www.elixirr.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ELIX:LSE since
announced		Transaction
value
Insigniam LLCDeal completed11 Dec 202311 Dec 2023Deal completed70.32%--
Data delayed at least 20 minutes, as of Nov 21 2024 16:37 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.